Inspira Infrastructure Ltd. is a prestigious project by the promoters of Ajanta Pharma Ltd. - a niche formulations player in Ophthalmology, Dermatology, Cardiology and Orthopedic segments and the 6th largest pharmaceutical company in Ophthalmology segment in India. IMS (ORG) ranks Ajanta Pharma as one of the fastest growing pharmaceutical companies in India.

The Ajanta Group, established in 1973, has its presence in more than 52 countries. The company has three formulations manufacturing facilities in India and one at Mauritius. Ajanta is constructing an API (Active Pharmaceutical Ingredient) unit for captive use. Listed on the Bombay and National Stock Exchanges in India, the company’s annual sales were US$ 80 million (as on March 2008) with an annual CAGR of 21%.

Knowledge of the infrastructure requirements of Pharmaceutical companies, understanding of pain areas due to long standing in the industry and immaculate credentials of the promoters within the exporting community is a blessing and encouragement for the clients and investors in the project.

Ajanta's facilities in India and abroad have been approved by many important international bodies such as World Health Organization, UNICEF, MSF and PSF. Approvals have been received from international drugs and pharma regulatory bodies of various countries.

"ADVENT", the R&D centre located in Mumbai, India has an experienced staff of over 200 scientists. The team has been instrumental in developing many innovative products that have been introduced for the first time in the world. Their strength includes developing of Controlled - release and sustained release products.